321 related articles for article (PubMed ID: 31010462)
1. Current and Future Idiopathic Pulmonary Fibrosis Therapy.
Richeldi L; Baldi F; Pasciuto G; Macagno F; Panico L
Am J Med Sci; 2019 May; 357(5):370-373. PubMed ID: 31010462
[TBL] [Abstract][Full Text] [Related]
2. Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Rogliani P; Calzetta L; Cavalli F; Matera MG; Cazzola M
Pulm Pharmacol Ther; 2016 Oct; 40():95-103. PubMed ID: 27481628
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic advances in idiopathic pulmonary fibrosis.
Fraser E; Hoyles RK
Clin Med (Lond); 2016 Feb; 16(1):42-51. PubMed ID: 26833513
[TBL] [Abstract][Full Text] [Related]
4. Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done?
Inchingolo R; Condoluci C; Smargiassi A; Mastrobattista A; Boccabella C; Comes A; Golfi N; Richeldi L
Expert Opin Pharmacother; 2017 Oct; 18(15):1583-1594. PubMed ID: 28933616
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targets in idiopathic pulmonary fibrosis.
Kolb M; Bonella F; Wollin L
Respir Med; 2017 Oct; 131():49-57. PubMed ID: 28947042
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic pulmonary fibrosis: pathogenesis and management.
Sgalla G; Iovene B; Calvello M; Ori M; Varone F; Richeldi L
Respir Res; 2018 Feb; 19(1):32. PubMed ID: 29471816
[TBL] [Abstract][Full Text] [Related]
7. Treatment of idiopathic pulmonary fibrosis with Nintedanib: an update.
Wongkarnjana A; Yanagihara T; Kolb MR
Expert Rev Respir Med; 2019 Dec; 13(12):1139-1146. PubMed ID: 31564185
[No Abstract] [Full Text] [Related]
8. Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group.
Sköld CM; Bendstrup E; Myllärniemi M; Gudmundsson G; Sjåheim T; Hilberg O; Altraja A; Kaarteenaho R; Ferrara G
J Intern Med; 2017 Feb; 281(2):149-166. PubMed ID: 27862475
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years.
Raghu G
Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29074545
[TBL] [Abstract][Full Text] [Related]
10. Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centre.
Bargagli E; Piccioli C; Rosi E; Torricelli E; Turi L; Piccioli E; Pistolesi M; Ferrari K; Voltolini L
Pulmonology; 2019; 25(3):149-153. PubMed ID: 30236523
[TBL] [Abstract][Full Text] [Related]
11. The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosis.
Aiello M; Bertorelli G; Bocchino M; Chetta A; Fiore-Donati A; Fois A; Marinari S; Oggionni T; Polla B; Rosi E; Stanziola A; Varone F; Sanduzzi A
Pulm Pharmacol Ther; 2017 Jun; 44():7-15. PubMed ID: 28257817
[TBL] [Abstract][Full Text] [Related]
12. Practical considerations in the pharmacologic treatment of idiopathic pulmonary fibrosis.
King CS; Nathan SD
Curr Opin Pulm Med; 2015 Sep; 21(5):479-89. PubMed ID: 26164298
[TBL] [Abstract][Full Text] [Related]
13. Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial.
Vancheri C; Kreuter M; Richeldi L; Ryerson CJ; Valeyre D; Grutters JC; Wiebe S; Stansen W; Quaresma M; Stowasser S; Wuyts WA;
Am J Respir Crit Care Med; 2018 Feb; 197(3):356-363. PubMed ID: 28889759
[TBL] [Abstract][Full Text] [Related]
14. Successful Concomitant Therapy with Pirfenidone and Nintedanib in Idiopathic Pulmonary Fibrosis: A Case Report.
Hagmeyer L; Treml M; Priegnitz C; Randerath WJ
Respiration; 2016; 91(4):327-32. PubMed ID: 27073887
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic pulmonary fibrosis: the turning point is now!
Funke M; Geiser T
Swiss Med Wkly; 2015; 145():w14139. PubMed ID: 26024356
[TBL] [Abstract][Full Text] [Related]
16. Recent evidence for pharmacological treatment of idiopathic pulmonary fibrosis.
Covvey JR; Mancl EE
Ann Pharmacother; 2014 Dec; 48(12):1611-9. PubMed ID: 25202034
[TBL] [Abstract][Full Text] [Related]
17. [Novel therapies for idiopathic pulmonary fibrosis].
Wand O; Kremer MR
Harefuah; 2015 Jul; 154(7):446-50, 469, 468. PubMed ID: 26380465
[TBL] [Abstract][Full Text] [Related]
18. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
George PM; Wells AU
Expert Rev Clin Pharmacol; 2017 May; 10(5):483-491. PubMed ID: 28266906
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence.
Robalo-Cordeiro C; Campos P; Carvalho L; Borba A; Clemente S; Freitas S; Furtado S; Jesus JM; Leal C; Marques A; Melo N; Souto-Moura C; Neves S; Sousa V; Santos A; Morais A
Rev Port Pneumol (2006); 2017; 23(5):287-293. PubMed ID: 28668400
[TBL] [Abstract][Full Text] [Related]
20. An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis.
Aryal S; Nathan SD
Expert Opin Emerg Drugs; 2018 Jun; 23(2):159-172. PubMed ID: 29718783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
